|Mr. Nicholas John Cordeaux Walters||CFO, Sec. & Director||48k||N/A||1958|
|Dr. Matthew Stork||CEO & Director||N/A||N/A||N/A|
|Mr. John Hammond||Co-Founder||N/A||N/A||N/A|
|Mr. Nick Taptiklis||Head of Technology Strategy||N/A||N/A||N/A|
|Dr. Jenny H. Barnett||Chief Scientific Officer||N/A||N/A||N/A|
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops digital health products. The company offers CANTAB Recruit, an online patient recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from phases IIV or a cognitive testing software that enhances the chances of success and minimizing the risk of failure in neuroscience research; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication. It also provides CANTAB Connect Research, a research software that offers sensitive digital measures of cognitive function for various areas of brain research; CANTAB Mobile, a touchscreen memory test used in clinical research of Alzheimer's disease; CANTAB BrainHealth, an online digital health assessment tool to measure and monitor mental wellbeing and cognitive performance in the workplace; CANTAB Insight, a medical device that helps to determine an individual's cognitive health; and Cognitive health and wellbeing, which Optimize mental wellbeing and performance throughout the life. The company was incorporated in 2012 and is based in Cambridge, the United Kingdom.
Cambridge Cognition Holdings Plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.